Bamboos Health Care Holdings Limited (2293.HK) issued a notice detailing its 2025 Annual General Meeting (AGM), which is set for 28 November 2025 at 11:00 a.m. Key proposals include granting general mandates for share issuance (up to 20% of issued shares) and share buy-back (up to 10% of issued shares), as well as extending the share issuance mandate by adding any shares bought back. These mandates will remain valid until the next AGM or until revoked or varied by shareholder resolution.

The company recommends re-electing three retiring directors, namely one executive director, Mr. Cheng Sau Kong, and two independent non-executive directors, Mr. Tang Yi Hoi and Mr. Wong Kon Man Jason. The auditor, HLB Hodgson Impey Cheng Limited, is recommended for re-appointment for the next financial year.

A final dividend of HK1.50 cents per share is proposed for the year ended 30 June 2025. Subject to shareholder approval, the dividend record date is set for 5 December 2025, and shareholders whose names appear in the register on that date would be entitled to receive the dividend, scheduled to be paid on or around 18 December 2025.

For the purpose of determining the right to attend and vote at the AGM, the register of members will be closed from 21 November 2025 to 28 November 2025. For entitlement to the final dividend, it will be closed again from 5 December 2025 to 8 December 2025. During these periods, no share transfers will be registered.